Neonatal thermoregulation devices aid in monitoring and regulating the body temperature of newborn babies in the intensive care unit. Devices such as neonatal incubators provide heat, humidity, ventilation, and protection from infections to support the growth and development of premature infants. The rising cases of preterm births globally have increased the demand for such devices. According to the World Health Organization (WHO), an estimated 15 million babies are born premature each year. Premature birth complications are the leading cause of death among children under 5 years of age.

The global Neonatal Thermoregulation Devices Market is estimated to be valued at US$ 47.27 Mn  in 2023 and is expected to exhibit a CAGR of 7.4% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

One of the key trends driving the neonatal thermoregulation devices market is the growing adoption of innovative devices. Manufacturers are focusing on developing devices equipped with advanced features such as powerful heating systems, automated controls, real-time temperature and humidity monitoring, integrated incubators with radiant warmers, and connectivity with hospital information systems. For instance, Dräger Medical GmbH offers Inkubator 8000PLUS, an innovative neonatal incubator providing optimal thermal comfort, low noise levels, and online connectivity solutions for remote monitoring and documentation. Such advanced devices improve preterm infant care and support better clinical outcomes. This is expected to boost the demand for innovative neonatal thermoregulation devices over the forecast period.

Segment Analysis
Neonatal Thermoregulation Devices Market comprises incubators, infant radiant warmers, neonatal heating pads and conection cables. Incubators dominate the market accounting for over 35%. Incubators provide stable temperature and humidity controlled environment ideal for newborn care. They help maintain normal body temperature in newborns, especially preterm and low birth weight babies who have difficulty maintaining normal temperature.

Key Takeaways
Global Neonatal Thermoregulation Devices Market Size is expected to witness high growth. The global Neonatal Thermoregulation Devices Market is estimated to be valued at US$ 47.27 Mn  in 2023 and is expected to exhibit a CAGR of 7.4% over the forecast period 2024 to 2031.

Regional analysis
North America currently dominates the global market accounting for over 40% share. Rising preterm birth rates and increasing healthcare spending in the region are driving the market. Asia Pacific is expected to be the fastest growing region during the forecast period aided by growing awareness, improving accessibility and rising healthcare investments in major countries like India and China.

Key players
Key players operating in the Neonatal Thermoregulation Devices Market are Sysmex Corporation (Japan), Danaher Corporation (US), Nihon Kohden (Japan), Siemens (Germany), Abbott (US), Boule Diagnostics (Sweden), HORIBA (Japan), Bio-Rad Laboratories (US), BioSystems (Spain), Diatron (Hungary), Drew Scientific (US), EKF Diagnostics (UK), Mindray (China), Ortho Clinical Diagnostics (US), and Roche (Switzerland), among others.

Get More Insights On This Topic: https://www.pressreleasebulletin.com/the-neonatal-thermoregulation-devices-market-is-expected-to-be-flourished-by-growing/

Explore More Related Article: https://click4r.com/posts/g/14442386/